Abstract
The third-“generation” cephalosporin antibiotics (Table 1) represent a class of agents with an expanded gram-negative spectrum of activity beyond that of the first- and second-“generation” cephalosporins. Greater stability to beta-lactamases produced by gram-negative organisms confers to these agents a greater bactericidal action against the Enterobacteriaceae. Large bacterial inocula (105/ml) in vitro significantly increase the minimum inhibitory and bactericidal concentrations (MIC and MBC) explaining treatment failures with these agents in infections associated with large numbers of organisms. The pharmacokinetic features of some of the agents allow prolongation of dosing intervals, and enhanced tissue penetration amplifies their clinical utility in infections distant from the bloodstream (eg, meningitis).
Publisher
Cambridge University Press (CUP)
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Things We Do for No Reason™: Prescribe cefdinir for treatment of common infections;Journal of Hospital Medicine;2024-06-02
2. Ceftazidime/Avibactam: Who Says You Can’t Teach an Old Drug New Tricks?;Journal of Pharmacy & Pharmaceutical Sciences;2016-11-04
3. Update on Antimicrobial Agents;Nursing Clinics of North America;1991-06
4. Dioxopiperazines: Chemistry and biology;Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques;1990
5. Cephalosporin, Carbapenem, and Monobactam Antibiotics;Mayo Clinic Proceedings;1987-09